ESC Congress 2026 · Munich · 28–31 August

特殊人群心血管疾病

CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS
1重点场次
44中国报告
5卫星会系列
01重点学术场次Priority Sessions1 场
本专题的重点场次包含 Hot Line、LBCS、New ESC Guidelines、Ask the Trialists、Guidelines in Practice、Great Debates 等。
肿瘤心脏病学1 场
LBCS
晚期临床科学:肿瘤心脏病学
Late-Breaking Clinical Science: cardio-oncology
时间08-30 11:00
主席Jutta Bergler-Klein; Pietro Ameri
前列腺癌患者心血管与生活方式危险因素随机干预研究
A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Darryl Leong · 讲者 · Population Health Research Institute·08-30 11:00
全球首发
HER2 靶向治疗相关心脏功能障碍恢复后停用药物治疗安全性的开放标签随机对照试验
An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.
Benjamin Dowsing · 讲者 · University College London·08-30 11:00
全球首发
癌症患者动脉血栓的发生率与预测因素:前瞻性 COMPASS 癌症相关动脉血栓(COMPASS-ARTeCAT)研究
Incidence and Predictors of Arterial Thrombosis in Cancer Patients: The Prospective COMPASS-Arterial Cancer Associated Thrombosis (COMPASS-ARTeCAT) Study
Maria Drakopoulou · 讲者 · University of Athens·08-30 11:00
全球首发
心力衰竭与血液系统恶性肿瘤新发风险:全国人群队列研究
Heart Failure and Incident Hematologic Malignancies: A Nationwide Population-Based Cohort Study
So-Young Lee · 讲者 · Seoul St. Marys Hospital·08-30 11:00
全球首发
03本领域中国研究China Abstracts44 篇
研究标题第一作者所在机构
心脏肿瘤学 · 14 篇
IgG N-糖基化作为免疫检查点抑制剂相关心肌炎的新型生物标志物:比较糖组学研究
IgG N-glycosylation as a novel biomarker for immune checkpoint inhibitor-associated myocarditis: a comparative glycomic study
08-28 08:15
Jingyi Li北京协和医院
免疫检查点抑制剂在亚洲人群中的真实世界心血管毒性:台湾全国注册研究的启示
Real-world cardiovascular toxicity of immune checkpoint inhibitors in an asian population: insights from a nationwide taiwanese registry
08-28 08:15
Kuan Ting Chen马偕纪念医院
中性粒细胞经NET/NETosis轴参与αPD1诱导的潜在心肌损伤:ICI相关心肌炎的病理机制、诊断标志物与治疗靶点探索
Neutrophils contribute to αPD1-induced latent myocardial injury via NET/NETosis axis: exploration of potential patho-mechanism, diagnostic biomarkers and therapeutic targets in ICIs-associated myocard
08-28 08:15
Yifan Chen厦门心脏中心
FOXA1+CD3+T淋巴细胞经DLL1/Notch1/GSDMD信号通路加重免疫检查点抑制剂相关心肌炎的心肌损伤
FOXA1+CD3+T lymphocytes exacerbate myocardial injury in immune checkpoint inhibitor associated myocarditis via the DLL1/Notch1/GSDMD signaling pathway
08-28 13:35
Xiaoling Liu山东大学齐鲁医院
循环DKK1升高与非小细胞肺癌早期肺血管重构相关
Elevated circulating DKK1 is associated with pulmonary vascular remodeling in early-stage non-small cell lung cancer
08-28 14:05
Mengmeng Li山东大学齐鲁医院
洛拉替尼与其他ALK抑制剂心血管与代谢特征比较:全球网络分析
Comparison of cardiovascular and metabolic profiles in lorlatinib vs. other ALK inhibitors in global network
08-29 14:15
Szu-Han Wang台南医院
淋巴瘤含蒽环类化疗后心血管不良事件的发生率与预测因素:回顾性纵向队列
Incidence and predictors of cardiovascular adverse events after anthracycline-containing chemotherapy in lymphoma: a retrospective longitudinal cohort
08-30 08:15
Dewan Zhao大连医科大学附属第一医院
急性冠脉综合征后的癌症特异性死亡率:全国真实世界队列的启示
Cancer-specific mortality after acute coronary syndrome: insights from a nationwide real-world cohort
08-30 14:15
Mingxuan Li中国心脏之家
新诊断多发性骨髓瘤的心血管不良事件:发生率、预测因素与预后影响
Cardiovascular adverse events in newly diagnosed multiple myeloma: incidence, predictors, and prognostic impact
08-30 14:15
Dewan Zhao大连医科大学附属第一医院
乳腺癌患者治疗后心肌损伤列线图预测模型的构建与验证
Construction and validation of a nomogram prediction model for myocardial injury in breast cancer patients after treatment
08-30 14:15
Yinyin Zhang中山大学孙逸仙纪念医院
VEGF–TKI所致高血压的独特血压变异表型:肿瘤心脏病学人群间的比较研究
Distinct blood pressure variability phenotype in VEGF–TKI–induced hypertension: a comparative study across cardio-oncology populations
08-31 10:15
Heng Yu兰州大学第二医院
Mdivi-1通过改善阿帕替尼诱导的Drp1介导的线粒体过度分裂降低荷胃癌裸鼠血压
Mdivi-1 reduces blood pressure in gastric cancer-bearing nude mice by ameliorating apatinib-induced Drp1-mediated excessive mitochondrial fission
08-31 10:15
Jing Yu兰州大学第二医院
C3a–C3aR1介导的心脏成纤维细胞与巨噬细胞交互驱动ICI相关心肌炎进展
C3a–C3aR1–mediated crosstalk between cardiac fibroblasts and macrophages drives the progression of ICI-associated myocarditis
08-31 12:15
Hongjian Dong东南大学附属中大医院
健康饮食模式与癌症幸存者新发心血管疾病:前瞻性队列研究
Healthy dietary patterns and incident cardiovascular disease in cancer survivors: a prospective cohort study
08-31 12:15
Qingyuan Gao中山大学孙逸仙纪念医院
肾功能衰竭与心血管疾病 · 9 篇
慢性肾脏病合并冠心病患者中复合胰岛素抵抗炎症生物标志物的预后分层:跨血糖状态分析
Prognostic stratification with composite insulin resistance inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses
08-29 13:15
Zixiang Ye国家心血管病中心、阜外医院心血管疾病国家重点实验室
术前肾功能、术后急性肾损伤与冠状动脉旁路移植术后5年死亡率:因果中介分析
Preoperative renal function, postoperative acute kidney injury, and 5-year mortality after coronary artery bypass grafting: a causal mediation analysis
08-30 10:55
Runze Chen国家心血管病中心、阜外医院心血管疾病国家重点实验室
亚洲大队列中不同KDIGO危险分层的远期心血管结局
Long-term cardiovascular outcomes across KDOKI risk categories in a large Asian cohort
08-30 11:25
Jui-Tzu Huang台北荣民总医院
CHA2DS2-VASc评分对伴与不伴既往心肌梗死房颤患者ESRD的不同预测效力
Different prediction power of ESRD by CHA2DS2-VASc score in AF patients with or without prior myocardial infarction
08-30 17:15
Pang Shuo Huang辅仁大学附设医院
沙库巴曲缬沙坦在射血分数减低型心力衰竭合并晚期慢性肾脏病中的心肾权衡:倾向加权多中心分析
Cardiorenal trade-off of sacubitril/valsartan in heart failure with reduced ejection fraction and advanced chronic kidney disease: a propensity-weighted multicentre analysis
08-31 14:15
Chien-Yi Hsu台北医科大学附设医院
肾功能不全急性心肌梗死患者中营养状态调节的LDL-C预后悖论:多中心回顾性队列研究
The prognostic paradox of LDL cholesterol modulated by nutritional status in acute myocardial infarction patients with renal impairment: a multicenter retrospective cohort study
08-31 14:50
Hao Zhang天津医科大学第二医院
心血管-肾脏-代谢重叠对NSTEMI患者预后的影响:多队列研究
Prognostic impact of cardiovascular-kidney-metabolic overlap among patients with non-ST-segment elevation myocardial infarction: a multi-cohort study
08-31 15:20
Jing Gao天津市胸科医院
单核细胞/淋巴细胞比值与估计肾小球滤过率对合并慢性肾脏病的AMI患者远期生存的协同影响
Synergistic impact of monocyte-to-lymphocyte ratio and estimated glomerular filtration rate on long-term survival in ami patients with chronic kidney disease
08-31 15:00
Xiaozhao Lu广东省人民医院
有创评估的延迟治疗介导了晚期慢性肾脏病NSTEMI患者四分之一的超额死亡:大规模多中心分析
The withholding of invasive assessment mediates one-quarter of excess mortality in NSTEMI patients with advanced chronic kidney disease: a large-scale multicenter analysis
08-31 15:10
Wenbo Dai天津医科大学第二医院
老年心血管疾病 · 6 篇
标准化多组分管理对心血管疾病患者医疗服务利用与费用的影响:纵向研究
Impact of standardized multicomponent management on healthcare utilization and costs among patients with cardiovascular disease: a longitudinal study
08-28 11:15
Weiping Cao乐山市人民医院
衰弱削弱急性心肌梗死中年龄的预后影响
Frailty attenuates the prognostic impact of age in acute myocardial infarction
08-29 15:15
Rongxin Guo天津医科大学第二医院
DNA甲基化(表观遗传)时钟尤其是GrimAge2的加速可预测老年人急性冠脉综合征发病
Acceleration of DNA methylation (epigenetic) clocks especially GrimAge2 can predict incident acute coronary syndrome in older adults
08-30 11:15
Erik Fung香港科技大学
衰弱对心血管-肾脏-代谢多病共存时间序列的影响:队列研究
Effect of frailty on the temporal sequence of cardiovascular-kidney-metabolic multimorbidity: a cohort study
08-30 11:15
Jingkuo Li国家心血管病中心、阜外医院心血管疾病国家重点实验室
替格瑞洛对比氯吡格雷治疗≥75岁STEMI老年患者的比较效果:目标试验模拟研究
Comparative effectiveness of ticagrelor versus clopidogrel in older adults (≥75 years) with ST-segment elevation myocardial infarction: a target trial emulation study
08-31 10:45
Rongxin Guo天津医科大学第二医院
CVMI-age量化多维度心血管衰老并预测心血管事件:中国社区队列研究
CVMI-age quantifies multidimensional cardiovascular aging and predicts cardiovascular events: a Chinese community-based cohort study
08-31 11:21
Haotai Xie北京大学第一医院
自身免疫性与慢性炎症性疾病 · 5 篇
冠心病合并类风湿关节炎患者的性别悖论:全国性队列研究
The "sex paradox" in patients with coexistent coronary heart disease and rheumatoid arthritis: a nationwide cohort study
08-28 13:15
Wenjie Chen首都医科大学附属北京朝阳医院
STEMI患者TET2-意义未明克隆性造血突变与hs-CRP的双向孟德尔随机化研究
Bidirectional mendelian randomzation study of TET2-clonal haematopoiesis of indeterminate potential-mutations with hs-CRP in patients with STEMI
08-30 15:15
Xiaoxiao Zhao国家心血管病中心、阜外医院心血管疾病国家重点实验室
血管老化是脂肪性肝病肝纤维化的早期驱动因素:揭示代谢依赖的治疗机会窗口
Vascular aging as an early driver of hepatic fibrosis in steatotic liver disease: unveiling a metabolic-dependent window of opportunity
08-30 15:15
Wei-Ting Wang台北荣民总医院
高同型半胱氨酸血症通过B细胞来源的抗β2糖蛋白I介导的内皮损伤加速动脉粥样硬化
Hyperhomocysteinemia accelerates atherosclerosis through a B cell–derived anti-β2 glycoprotein I–mediated endothelial injury
08-30 15:15
Hongyu Chen北京大学第一医院
基于血清标志物推断CD4+T细胞谱系转变的框架:动脉粥样硬化中的TPI模型
A serum-marker-based framework for inferring CD4+T-cell lineage shifts: introducing the tpi model in atherosclerosis
08-31 12:15
Caixia Lu河北省人民医院
女性心血管疾病 · 3 篇
肝功能不全急性心肌梗死患者的性别特异性LDL-C目标区间:真实世界队列分析
Gender-specific LDL-c target windows in acute myocardial infarction patients with liver dysfunction: a real-world cohort analysis
08-29 17:15
Rongxin Guo天津医科大学第二医院
心血管随机对照试验中性别代表性失衡对效应量的影响
Impact of sex-representation imbalance on effect sizes in cardiovascular randomized controlled trials
08-31 08:15
Xiaoying Zhong北京中医药大学东直门医院
重新审视转甲状腺素蛋白心肌病的室壁厚度:SMART国际队列中的性别差异
Rethinking wall thickness in transthyretin amyloid cardiomyopathy: sex-specific difference in the multinational SMART cohort
08-31 08:15
Yi-Hsin Hung台湾大学癌医中心
妊娠与心血管疾病 · 3 篇
孕前肥胖、不良妊娠结局模式与产后早期心脏代谢风险:潜类别分析识别的中介分析
Prepregnancy obesity, adverse pregnancy outcome patterns, and early postpartum cardiometabolic risk: a mediation analysis identified by latent class analysis
08-30 09:15
Jingge Li天津医科大学总医院
孕16周前使用阿司匹林与产后早期心脏代谢风险的关联:基于电子病历的研究
Association between aspirin use before 16 weeks of gestation and early postpartum cardiometabolic risk: an electronic health record–based study
08-30 15:45
Jingge Li天津医科大学总医院
母亲睡眠障碍通过中性粒细胞免疫代谢重编程驱动子痫前期
Maternal sleep disorders drive preeclampsia via immunometabolic reprogramming of neutrophils
08-31 09:15
Jie Zhu复旦大学
04企业卫星会Industry Symposia5 个系列
赞助商分布9 场 · AstraZeneca 8 场 · Boehringer Ingelheim 4 场 · Philips 2 场 · Siemens Healthineers 1 场 · Radcliffe
慢性肾病与心肾1 个系列
Radcliffe
心肾风险管理:基层医疗与心脏科的衔接
Cardiorenal risk management at the interface of primary care and cardiology
日程08-28
欢迎、介绍与课前测试
Welcome, introduction and pre-test
Richard Hobbs · 讲者 · Oxford, United Kingdom of Great Britain & Northern Ireland
心肾保护的基础:指南怎么说
The foundation of cardiorenal protection: what the guidelines say
Ileana Pina · 讲者 · Thomas Jefferson University
基于 SGLT2 抑制剂的策略优化管理
Optimising management with SGLT-2i-based strategies
Sarah Davies · 讲者 · United Kingdom of Great Britain & Northern Ireland
听众问答:明天即可用于临床的实用方案
Audience Q&A: practical solutions for your practice tomorrow
Richard Hobbs · 讲者 · Oxford, United Kingdom of Great Britain & Northern Ireland
要点回顾、课后测验与闭幕致辞
Key takeaways, post-test and closing remarks
Richard Hobbs · 讲者 · Oxford, United Kingdom of Great Britain & Northern Ireland
AI 与数字技术1 个系列
AstraZeneca
用人工智能重新定义遗传型 ATTR(ATTRv)的早期诊断(系列共 9 场)
Redefining early diagnosis of hereditary transthyretin amyloidosis (ATTRv) with artificial intelligence
日程08-28、08-29、08-30
用人工智能重新定义遗传性转甲状腺素蛋白淀粉样变性(ATTRv)的早期诊断
Redefining early diagnosis of hereditary transthyretin amyloidosis (ATTRv) with artificial intelligence
Francesco Cappelli · 讲者 · Careggi University Hospital (AOUC)
肿瘤心脏病学1 个系列
Siemens Healthineers
人工智能驱动心脏肿瘤学变革:从预测到预防(系列共 2 场)
Artificial intelligence powered transformation of cardio-oncology: from prediction to prevention
日程08-29、08-30
AI 驱动的肿瘤心脏病学变革:从预测到预防
Artificial intelligence powered transformation of cardio-oncology: from prediction to prevention
Tamara Kovacevic-Preradovic · 讲者 · University Clinical Centre of the Republic of Srpska
综合与其他2 个系列
Boehringer Ingelheim
基层心血管风险管理:面向基层医生的实践教程(系列共 8 场)
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorials for primary care physicians and professionals
日程08-28、08-29、08-30
基层医疗中的心血管风险管理:患者的突破——面向基层医生与专业人士的教程
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorialsl for primary care physicians and professionals
Pamela Kushner · 讲者 · Long Beach, United States of America
基层医疗中的心血管风险管理:患者的突破——面向基层医生与专业人士的教程
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorials for primary care physicians and professionals
Javier Morales · 讲者 · New York, United States of America
Philips
十分钟超快心脏磁共振应变评估:心脏毒性的诊断与管理(系列共 4 场)
10-min ultrafast CMR-based strain assessment for cardio-toxicity diagnosis and management
日程08-28、08-29、08-30、08-31
10 分钟超快速 CMR 应变评估用于心脏毒性诊断与管理
10-min ultrafast CMR-based strain assessment for cardio-toxicity diagnosis and management
Esther Perez-David · 讲者 · La Paz University Hospital
企业卫星会内容由赞助方支持,此处仅作学术日程信息陈列,不代表编辑立场。
✕ 关闭
Heart Failure and Incident Hematologic Malignancies
Heart Failure and Incident Hematologic Malignancies: A Nationwide Population-Based Cohort Study
已有发表积累
研究
注册号
NCT06033521
状态
已随访完成
期别/类型
— · OBSERVATIONAL
入组
1,036,294 人(1 国)
启动
2023-09-12
主要研究者
So-Young Lee · Seoul St. Marys Hospital - Seoul, Korea (Republic of)
主要终点
每年因更年期症状就诊的女性数 ① 每年使用绝经激素治疗的女性数 ① 每年按更年期症状类型分类的参与者数
文章
Journal of the American Heart Association · 2026 · PMID 42568058
Maternal ADs are independent risk factors for offspring structural CHD. These findings underscore the importance of multidisciplinary counseling and specialized fetal echocardiographic screening for pregnant women with ADs to ensure early detection and management of potential cardiac defects in their offspring.
Incidence and Predictors of Arterial Thrombosis in Cancer Patients
Incidence and Predictors of Arterial Thrombosis in Cancer Patients: The Prospective COMPASS-Arterial Cancer Associated Thrombosis (COMPASS-ARTeCAT) Study
全球首发信号
研究
注册号
NCT05256329
状态
未知
期别/类型
— · OBSERVATIONAL
入组
2,000 人(1 国)
启动
2021-01-01
主要研究者
Maria Drakopoulou · University of Athens - Athens, Greece
主要终点
症状性动脉血栓栓塞(任意住院诊断)复合终点
首发
会前无公开结果文献 —— ESC 2026 现场即全球首发的报道窗口
A RAndomizeD Intervention for CArdiovasc
A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
已有发表积累
研究
注册号
NCT03127631
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
5,000 人(9 国)
启动
2015-10-21
主要研究者
Darryl Leong · Population Health Research Institute - Hamilton, Canada
主要终点
心血管死亡、心肌梗死、卒中、心力衰竭、胆固醇控制(总胆固醇≤4mmol/L)和收缩压控制(≤130mmHg)层级复合终点 ① 心血管死亡、心肌梗死、卒中、心力衰竭复合终点首次发生时间
文章
Cureus · 2023 · PMID 38288190
Patients with PC have a greater likelihood of dying from CVD. Several important risk factors for CVD have been discovered, including advanced age, black ethnicity, and patients without surgical intervention. These findings are limited by the retrospective nature of the analysis, relying solely on the SEER database, which imposes restrictions on accessing comprehensive patient data, including lifestyle factors and medical history.
An open-label, randomised controlled tri
An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.
注册记录待核
文章
BMJ open · 2025 · PMID 39909533
A quarter of breast cancers show human epidermal growth factor-2 (HER2) overexpression, where targeted therapy dramatically improves survival. However, cancer therapy-related cardiac dysfunction (CTRCD) occurs in up to 15% of patients. With the interruption of HER2 therapy, if necessary, and the initiation of heart fai…
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)